Stocks in Play

Stem Cell Therapeutics Corp.

09:56 AM EST - Stem Cell Therapeutics Corp. : announced that a requested end of Phase II meeting has been reviewed by FDA and a meeting date has been set for December 20, 2010. Stem Cell Therapeutics Corp. shares V.SSS are trading even at $0.07.